Markets


Top Analyst Pounds the Table on Exelixis, Inc. (EXEL)

Cowen’s Eric Schmidt sees an extra several hundred million dollars in sales for EXEL in HCC market.

FDA Approved: Transenterix Inc (TRXC) Will Now Offer Surgical Robotic System in the US

Transenterix Inc (NYSEAMERICAN:TRXC) investors are overwhelmingly excited today after the medical device maker announced the Company has received FDA 510(k) clearance for the …

Leading Brands, Inc (USA) (LBIX) Reports Second Quarter Results; Shares Soar

Leading Brands, Inc (USA) (NASDAQ:LBIX) announced results for its second quarter of fiscal 2017, which ended August 31, 2017.  All financial amounts are …

Why Recon Technology, Ltd. (RCON) Stock Doubled Today

It’s a very rewarding trading day for investors in Recon Technology, Ltd. (NASDAQ:RCON) with shares up over 120%, making the stock Wall Street’s …

Company Update (NASDAQ:MU): Micron Technology, Inc. Names Manish Bhatia as EVP of Global Operations

Micron Technology, Inc. (NASDAQ:MU) announced the appointment today of Manish Bhatia as executive vice president of Global Operations.

Why Exelixis, Inc. (EXEL) Shares Took Off Today

Exelixis, Inc. (NASDAQ:EXEL) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 30% upturn.

Company Update (NYSE:GE): General Electric Company Appoints Rafael Santana as GE Transportation CEO

General Electric Company (NYSE:GE) announced that Rafael Santana, president and CEO of GE Latin America, has been named president and CEO of GE Transportation, …

Company Update (NASDAQ:CLSN): Celsion Corporation Announces Publication of the HEAT Study Manuscript in Clinical Cancer Research Journal 

Celsion Corporation (NASDAQ:CLSN) announced publication of the manuscript, “Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable …

Joseph Edelman’s Take on 3 Small Cap Biotech Stocks: AcelRx Pharmaceuticals Inc (ACRX), Synergy Pharmaceuticals Inc (SGYP), Antares Pharma Inc (ATRS)

This market-beating fund manager is slashing ACRX and SGYP, but upping ATRS.

Netflix, Inc. (NFLX) Draws Out Its Biggest Bull Ahead of Q3 Print Tonight, Snap Inc (SNAP) Popularity Wins Over Millennials More Than Advertisers

Goldman Sachs: NFLX will outclass uplifted forecasts; Aegis: SNAP skirts downside risk in advertising growth.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts